levorichter 30 continu 0,15 mg - 0,030 mg omh. tabl.
gedeon richter plc - levonorgestrel 150 µg (witte tablet); ethinylestradiol 30 µg (witte tablet); placebo (groene tablet) - omhulde tablet - 0,15 mg - 0,030 mg - ethinylestradiol 30 µg; levonorgestrel 150 µg; placebo - levonorgestrel and ethinylestradiol
lindynette 20 0.02 mg - 0.075 mg omh. tabl.
gedeon richter plc - ethinylestradiol 0,02 mg; gestodeen 0,075 mg - omhulde tablet - 0,020 mg - 0,075 mg - ethinylestradiol 20 µg; gestodeen 75 µg - gestodene and ethinylestradiol
lindynette 30 75 µg - 30 µg omh. tabl.
gedeon richter plc - ethinylestradiol 0,03 mg; gestodeen 0,075 mg - omhulde tablet - 75 µg - 30 µg - ethinylestradiol 30 µg; gestodeen 75 µg - gestodene and ethinylestradiol
lumivela continu 20 0.15 mg - 0.02 mg filmomh. tabl.
exeltis germany gmbh - desogestrel 0,15 mg (witte tablet); ethinylestradiol 0,02 mg (witte tablet); placebo (groene tablet) - filmomhulde tablet - 0,150 mg - 0,020 mg - desogestrel 0.15 mg; ethinylestradiol 0.02 mg; placebo - desogestrel and ethinylestradiol
microgynon 20 0.1 mg/0.02 mg omh. tabl.
bayer sa-nv - ethinylestradiol 0,02 mg; levonorgestrel 0,1 mg - omhulde tablet - 0,100 mg - 0,020 mg - ethinylestradiol 20 µg; levonorgestrel 100 µg - levonorgestrel and ethinylestradiol
noranelle 30 µg - 150 µg filmomh. tabl.
ceres pharma sa-nv - ethinylestradiol 0,03 mg; levonorgestrel 0,15 mg - filmomhulde tablet - 30 µg - 150 µg - ethinylestradiol 30 µg; levonorgestrel 150 µg - levonorgestrel and ethinylestradiol
noranelle 20 µg - 100 µg filmomh. tabl.
ceres pharma sa-nv - levonorgestrel 0,1 mg; ethinylestradiol 0,02 mg - filmomhulde tablet - 20 µg - 100 µg - levonorgestrel 100 µg; ethinylestradiol 20 µg - levonorgestrel and ethinylestradiol
nexpovio
stemline therapeutics b.v. - selinexor - multiple myeloma - antineoplastische middelen - nexpovio is indicatedin combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. in combination with dexamethasone for the treatment of multiple myeloma in adult patients who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, two immunomodulatory agents and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
noranelle 20 µg - 100 µg filmomh. tabl.
ceres pharma sa-nv - levonorgestrel 0,1 mg; ethinylestradiol 0,02 mg - filmomhulde tablet - levonorgestrel and ethinylestradiol
cometriq
ipsen pharma - cabozantinib - schildklierneoplasma - antineoplastische middelen - behandeling van volwassen patiënten met progressief, niet-reseceerbaar lokaal gevorderd of gemetastaseerd medullair schildkliercarcinoom.